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1. Introduction 
Cross-sectional prospective surveys are a useful method for studying the effects of 
antimicrobials on animals (Dunowska et al., 2006; Thomson et al., 2008; Bunner et al., 2007) . 
However, there is a paucity of these studies in horses compared to other animals (Coe et al., 
2008). 
Although antibiotic consumption has been a major contributor to the antibiotic resistance 
phenomenon (Bunner et al., 2007) various different factors have added to the development 
and dissemination of antimicrobial resistance. For example, population densities among 
humans have been identified as risk factors for development and spread of antimicrobial 
resistance (Bruinsma et al., 2005; Zhang et al., 2006). Hospitalization, in humans for instance, 
is also associated with an increase in antibiotic resistance in pathogenic bacteria, while 
others have found a lack of a significant effect on the prevalence of resistance in E. coli 
(Koterba et al., 1986; Gaynes et al., 1997). A study by Dunowska and colleagues (Dunowska 
et al., 2006) concluded that both antimicrobial administration and hospitalization were 
associated with the shedding of E. coli resistant strains from equine faecal samples. 
Certain antimicrobial administration regimes have been shown to give rise to antibiotic 
resistant bacteria, which then comprise a reservoir of resistant bacteria when shed into the 
environment (Ahmed et al., 2010; Fofana et al., 2006; Diarrassouba et al., 2007; Pallecchi et 
al., 2007). Linked resistance genes encoded on mobile genetic elements, can also contribute 
to the spread of resistance genes (Srinivasan et al., 2007), with exposure to one antimicrobial 
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agent leading to selection for resistance against other, or multiple, antimicrobial drugs 
(Braoudaki et al., 2007; Schnellmann et al., 2006; Weese et al., 2006). Such genes can be 
maintained after antibiotic treatment, has been stopped such that removing the selective 
pressure does not necessarily lead to the loss of resistance (Ahmed et al., 2010; Kaszanyitzky 
et al., 2007; Ghidan et al.,2008). Mobile genetic elements are widely reported cause of the 
spread of antibiotic resistance in both E. coli and Salmonella commensals in animals bred for 
human consumption (Roest et al., 2007). Therefore, E. coli and other enteric organisms are 
widely used as an indicator organism (Kaneene et al., 2007; Bruinsma et al., 2003).  
The purpose of this investigation was to identify changes in antibiotic resistant E. coli in 
faeces of horses entering the Philip Leverhulme Equine Hospital (PLEH), at the University 
of Liverpool, UK on arrival, during hospitalization, and after discharge. The dynamics 
affecting the prevalence of antibiotic resistant E. coli were used in this study in order to 
examine potential risk factors.  
2. Materials and methods 
2.1 Study design  
Faecal samples were collected from horses admitted to the Philip Leverhulme Equine 
Hospital (PLEH) at the University of Liverpool for more than seven days at the following 
time points: 1st, on arrival, before treatment began; 2nd, one day; 3rd, 2-3 days after treatment 
had started; 4th, immediately before discharge. Further faecal samples were collected by the 
horse’s owners, 4-8 weeks after discharge (5th), and also 6 months after discharge (6th). 
Horses were divided into three groups as follows: GI+, horses with gastrointestinal 
conditions and under antibiotic therapy; Non-GI+, horses with non-gastrointestinal 
conditions and under antibiotic therapy; Non-GI-, horses with non-gastrointestinal 
conditions and no antibiotic therapy. 
2.2 Sample collection  
Faecal samples were taken from stalls randomly and chosen from the firm part of the faecal 
balls. In total, 2-3 grams were collected and taken straight to the laboratory.  
2.3 Bacterial culture   
Standard microbiological methods and biochemical tests were used to isolate and confirm 
each E. coli as fully described by Ahmed et al 2010. Three single E. coli colonies were chosen 
from each sample, confirmed by biochemical testing (e.g. API system) and subjected to 
further susceptibility tests thereafter.  
2.4 Antibiotic susceptibility tests  
Antibiotic susceptibility testing was performed according to the BSAC guidelines (Andrews, 
2008). Briefly, antimicrobial drugs tested for included: - ampicillin; if the isolates show 
resistance to ampicillin then isolates were also tested against other two cephalosporins 
(cefotaxime (30 μg) and ceftazidime (30μg) for extended resistance to cephalosporines and 
referred as potential ESBL producers (ESBLs*) for ampicillin resistant isolates), apramycin, 
chloramphenicol (and also against florfenicol, if chloramphenicol resistant), nalidixic acid 
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(and also against ciprofloxacin, if nalidixic acid resistant), tetracycline and trimethoprim. 
Further susceptibility tests were also performed for gentamicin, spectinomycin, 
streptomycin and sulphamexazole for all collected resistant isolates. Isolates were 
considered resistant if resistance to at least one antibiotic was shown and classified as 
multidrug resistant isolates (MDR) if resistant to four or more classes of antibiotics (Ahmed 
et al., 2010). Guidelines for determining florfenicol and apramycin resistance were as 
followed and determined by Ahmed et al., 2010. 
2.5 Identification of antibiotic resistance genes in resistant E. coli isolates  
DNA was extracted by boiling: a 5µl drop of each isolate was suspended in 0.5 ml sterile 
water and heated for 20 minutes at 100°C. PCR assays, previously applied by Ahmed et al 
2010 were also used to detect genes commonly associated with ampicillin, chloramphenicol, 
tetracycline and trimethoprim resistance, were carried out using modified versions of 
published protocols: Pitout, 1998 (Pitout et al., 1998) for ampicillin resistant genes (tem & shv 
genes);  Vassort-Bruneau, 1996 (Vassort-Bruneau et al., 1996) and Keyes et al.,2000 (Keyes et 
al., 2000) for chloramphenicol resistant genes (catI, catII catIII & cmlA genes); Ng, 2001 (Ng et 
al., 2001) for tetracycline resistant genes (tetA, tetB, tetC, tetD, tet E and tetG genes); Gibreel & 
Sköld, 1998 (Gibreel et al., 1998) and Lee, 2001 (Lee et al., 2001) for trimethoprim resistant 
genes (dfr1, dfr9 dfr12, dfr13, dfrA14 & dfr17 genes). 
2.6 Statistical data analysis  
Data were analysed using Minitab software, in order to determine the 95% binomial 
confidence intervals (95%CI) and chi-square test (Χ2). 
2.7 Conjugation assays  
Mating experiments to determine if resistance could be transferred by conjugation were 
carried out using a nalidixic acid resistant E. coli K12 as the recipient (as performed by 
Ahmed et al., 2010). The method was as following: E. coli K12 was inoculated into 20ml 
nutrient broths (LabM) and incubated overnight at 37°C. Resistant E. coli strains (donor 
strains) were inoculated into separate 3ml nutrient broths and incubated overnight; 4 ml of 
recipient strain was then added to the donor strain and incubated at 37°C for one hour. 
Broths were then streaked onto agar plates containing nalidixic acid (30µg/ml) plus 
ampicillin (8µg/ml). Plates were incubated for 24 hours. Successful transconjugants were 
subcultured onto nutrient agar for susceptibility testing by disc diffusion as previously 
described. The resistance profiles of the transconjugants were compared to the resistance 
profile of the original strains. Gene profiles of the donor isolates, characterized by PCR, 
were described prior to the tranconjugation experiments 
3. Results 
3.1 Prevalence of antibiotic resistant (AR) E. coli isolate 
In total, 15 horses were used for the study: GI+ (n=6 horses), non-GI+ (n=4 horses) and non-
GI- (n=5 horses). Six samples were collected from each horse (n=90 in total).  The 
distribution of antibiotic resistance is presented in Tables 1 and 2. 
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Cohort   
group 
No. of 
horses 
No. of 
samples 
collected 
No. of samples 
positive for 
AR E. coli (%) 
Distribution of resistant samples(out of 
possible 6) for each sampling time 
1st        2nd         3rd          4th         5th        6th 
GI + 6 36 21 (58%) 2           4           5     5    3          2 
NON GI 
+ 
4 24 18 (75%) 3           4           4           4           3          0 
NON GI 
– 
5 30 16 (53%) 1           3           4           4           4          0 
Table 1. The number of horses, faecal samples collected and faecal samples positive for at 
least one antibiotic resistant (AR) E. coli isolate 
 
Source of 
samples 
Samples 
collected
Positive  
samples
Distributing of  samples containing E. coli 
resistant isolates to different antibiotics 
  AMP   CEP   APR   CHL   FLO   NAL   CIP   TET   TRI   MDR 
GI + 36 21    15         1           1         5         5         8         6        15      19        8 
NON GI + 24 18    12        10          0        10        0        11       11       11      18       11 
NON GI – 30 16    14         4           0         7         2         7         5        11       13       10 
*Abbreviations: Ampicillin (AMP), Cephalosporins (CEP), Apramycin (APR), Chloramphenicol (CHL), 
Florfenicol (FLO), Nalidixic acid (NAL), Ciprofloxacin (CIP), Teracycline (TET), Trimethoprim (TRI), 
MDR (multidrug resistance i.e. resistance to four or more antimicrobials), *ESBLs* isolates show 
resistance to ampicillin then isolates were also tested against other two cephalosporins (cefotaxime (30 
μg) and ceftazidime (30μg) for extended resistance to cephalosporines andreferred as potential ESBL 
producers (ESBLs*)   
Table 2. Summary of horses, faecal samples, faecal samples containing resistant E. coli, and 
the number of faecal samples with E. coli resistant  to each individual antibiotic  
The proportion of samples with at least one E. coli isolate resistant to at least one antibiotic 
ranged from 53-75% but did not vary significantly between treatment groups (GI +, non-
GI+, non GI-) (Table1). All three treatment groups also showed a similar change in 
prevalence of resistant isolates recovered over the duration of the study (Table1).  
Furthermore, there were no significant differences in the antibiotic resistance profiles of the 
isolates in each group (Table2). Therefore, data from the three groups were subsequently 
combined for the analysis of changing resistance over time. A definite pattern was observed 
in the prevalence of overall resistance, which increased from 40 +/-6 % at the first time 
point, immediately prior to admission, to 86 +/- 28 % during hospitalization (3rd time 
point), and decreased to 12 +/- 30 % after release (6th time point) (Figure1).  
To compare the prevalence of resistant isolates before hospitalisation, immediately before 
discharge and 6 months after discharge (at 1st, 4th and 6th time points respectively), data was 
analysed by Χ2 testing, analysing each individual antimicrobial as well as multidrug 
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resistance. With the exception of ampicillin, isolates resistant to each antimicrobial drug and 
multidrug resistant isolates (MDR) (i.e. isolates resistant to ≥ 4 antibiotic classes), increased 
significantly during hospitalization and decreased after the horses had returned home 
(Table3). The numbers of isolates resistant to florfenicol were too low for statistical analysis.  
 
Fig. 1. Relationship between sampling time and the proportion of samples with ≥ one isolate 
resistant to at least one antibiotic (with 95% binomial CI); total from all three treatment 
groups  GI+, non-GI+ and non-GI are combined (table1). 
Prevalence of antibiotic resistance at 
sampling times 
Sampling times 
1 & 4 
Sampling times 
4 & 6 
Χ2              p Χ2                  p 
Resistant to at least one antibiotic  7.03         ≤ 0.01 13.4          ≤ 0.001 
Amp 3.394       ≥ 0.05 9.600        ≤ 0.01 
Cep 6.000       ≤ 0.05 6.000        ≤ 0.05 
Chlo 6.136       ≤ 0.05 9.130        ≤ 0.01 
Nal 7.500       ≤ 0.01 7.500        ≤ 0.01 
Cip 7.500       ≤ 0.01 7.500        ≤ 0.01 
Tet 15.000     ≤ 0.001 11.627       ≤ 0.001 
Tri 10.995     ≤ 0.001 13.393       ≤ 0.001 
MDR 10.909     ≤ 0.001 10.109       ≤ 0.001 
Table 3. Two Χ2 tests (2x2 analysis) to compare the effect of hospital admission and 
discharge on prevalence of resistance to particular antibiotic drugs.  
3.2 Susceptibility testing of culture collection 
In total, 138 E. coli isolates resistant to at least one antibiotic were collected. Of these, 71 
(51.4%) were classified as MDR. Among these, two main distinctive MDR phenotypes (Phs) 
were found: Phs1;Amp,chlo,tet,tri,nal, comprising 93% of the MDR isolates, and mostly 
found among non-GI + samples; Phs2; Amp,chlo,tet,tri comprised 50% of the MDR isolates 
among the GI+ and the non-GI- samples. All the resistant isolates (n=138) were tested for 
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susceptibility to further antibiotics. Overall, 38.5% were resistant to gentamicin, 71% to 
spectinomycin, 96% to streptomycin and 90% to sulphamexazole.  
3.3 Molecular analysis of culture collection  
PCRs revealed that CatI [only](87%), tem(60.8%), tetA(60.8%, dfr17(50.4%), dfr1(38.5%) were 
identified at higher prevalence among each positive collection of resistant isolates to each 
antibiotic (table4). MICs were also shown at higher values of ≥256 for most isolates to the 
selected drugs (table4). 
 
Antibiotic  
No. of 
Positive 
Sample 
No. of 
Positive 
Isolates
MICs (ug/ml) Resistance genes 
Ampicillin 41 95 128 - >256 
tem (60.8%) 
shv (2%) 
Cephalosporines 15 34  
Chloramphenicol 22 51 256 - ≥256 catI (only) (87%) 
Florfenicol 7 7 catI (71%) 
Nalidixic acid 26 65  
Ciprofloxacin 22 64 4 – 16  
Tetracycline 37 89 64 - ≥256 
tetA (60.8%) 
tetB (19%) 
tetA&tetB(11.9%) 
Trimethoprim 50 127 >256 
dfr17 (50.4%) 
dfr1 (38.5%) 
dfr12 (20%) 
Table 4. Summary of antibiotic resistance, showing levels of resistance, MIC values and 
resistance gene prevalence in a total of 90 faecal samples and 138 isolates.  
3.4 Conjugation experiments  
Mating experiments were performed on selected isolates (n=73); those exhibiting nalidixic 
acid resistance were excluded 16 isolates (22% of the selected isolates & 11% of the overall 
culture collection) were able to transfer resistance by conjugation, and these were distributed 
across all cohort groups. Resistance profiles of the transconjugants, determined by 
susceptibility testing on the transconjugant, were identical to those of the donors (Table 5).  
4. Discussion 
Previous studies have given rise to conflicting conclusions as to whether or not hospitalization 
is associated with an increase in antibiotic resistance in bacteria (Bruinsma et al., 2003; Koterba 
et al., 1986). Factors other than the use of antimicrobial drugs could influence the maintenance 
and development of antibiotic resistance of enteric bacteria in the gastrointestinal tract (Dewulf 
et al., 2007). The use of antibiotics in animals is of concern (Mora et al., 2005) since resistant 
organisms might be excreted in the faeces of animals, following administration of 
antimicrobials, and contribute to the reservoir of resistant bacteria in the environment (Ahmed 
et al., 2010). Resistant bacteria could be selected or acquired in the hospital environment and 
may subsequently be disseminated to the horses’ home environments. 
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No. Origin Resistance phenotype 
Donor genes 
(previously identified by PCR) 
1, 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
NON-GI- 
NON-GI- 
NON-GI- 
NON-GI- 
NON-GI- 
NON-GI- 
NON-GI- 
GI+ 
GI+ 
GI+ 
GI+ 
GI+ 
GI+ 
GI+ 
GI+ 
NON-GI + 
AMP 
AMP 
MDR 
MDR 
MDR 
MDR 
MDR 
AMP 
AMP,TRI 
AMP,TRI 
AMP 
AMP 
AMP 
AMP,TRI 
AMP,TRI 
AMP 
Tem 
Tem 
dfr1,dfr12,tetA,tem,catI 
dfr1,dfr12,tetA,tem 
dfr1,dfr12,tetA,tem,catI 
tem 
dfr1,dfr12,tetA,tem 
tem 
dfr(7-17) 
not identified 
tem 
tem 
tem 
dfr1 
tem 
tem 
Table 5. Characteristics of isolates showing of transferable resistance. 
This study and in contrast with others found no obvious association between antibiotic 
treatment, or clinical condition, and resistance profiles in faecal E. coli. This may be due to 
the relatively small sample size, or because horses entering the PLEH are largely referral 
cases and likely to have received antibiotic therapy prior to admission.  
However, overall resistance to most individual antibiotics, and the proportion of MDR 
isolates increased during hospitalization and thereafter decreased during convalescence in 
the home environment. Recent studies by Dunowska et al, on horses, concluded that both 
hospitalization and antimicrobial administration were associated with the shedding of 
antimicrobial resistance E. coli strains of faecal origin (Dunowska et al., 2006). An earlier 
study, from a university equine hospital, found that the rate of resistance amongst E. coli 
and Klebsiella was higher at day seven of hospitalization compared to day one (Koterba et 
al., 1986). This may be due to selection during hospitalization through antibiotic therapy, 
and also the ready availability of resistant isolates in the hospital environment. It would be 
interesting to undertake PFGE analysis of the E. coli over time to investigate whether 
resistance is due to infection with resistant strains or horizontal transmission of resistance to 
the existing gut flora. 
Antimicrobials select for resistance (Tenover et al., 2006) but the restriction of antimicrobials 
does not necessarily reduce antimicrobial resistance (Hoyle et al., 2006). In our study, the 
prevalence of resistant E. coli dropped markedly after discharge from the hospital, which 
may suggest that both the increase and decrease in resistance are due to turnover of E. coli 
between the gut and the environment.  
E. coli with simple and multiple antimicrobial resistance (MDR) has been widely 
documented (Fofana et al., 2006; Ahmed et al., 2010). Bacteria can acquire or develop 
resistance to antimicrobials in different ways, including acquisition of resistant genes. E. coli 
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has been indicated as a possible reservoir for antimicrobial resistance genes and might play 
a role in the spreading of such determinants to other bacteria (Ahmed et al., 2010). The flora 
of healthy animals has also been implicated as a reservoir of antibiotic resistance genes (De 
Graef et al., 2004) and resistance transfer has been shown to occur between different animal 
species on farm premises (Hoyle et al., 2006). E. coli of animal origin with resistance to 
antibiotics and multiple antibiotics has been widely documented (Mora et al., 2005). The 
importance of farm animals in the spread of resistance to human populations is increased by 
worldwide reports of mobile genetic elements in animals raised for human consumption 
(Roest et al., 2007). 
Our results for MICs and the genetic determination of resistance, suggest that, resistance 
was due to commonly reported genes causing such resistance in E. coli and other bacteria. It 
is interesting to note, that while some MDR transferred in the conjugation studies, many 
transconjugants were resistant to either ampicillin alone or ampicillin and trimethoprim 
(table 5). This suggests that both resistance profiles are encoded on mobile genetic elements. 
Horses in the GI+ and non-GI+ groups were the donors for most of the Amp and 
Amp/Trim transconjugants, and all the horses in both groups received therapy with 
cephalosporin drugs. It may, therefore be that these isolates represent either an endemic 
strain in the hospital, or an endemic plasmid moving rapidly between horses. 
Multiple drug resistance phenotypes have been shown to be related to certain antibiotic 
drugs such as streptomycin and tetracycline (Mora et al., 2005). Also the resistance to a 
single antibiotic (i.e. tetracycline), in commensal E. coli, is linked to other antimicrobial 
resistances (e.g. ampicillin, trimethoprim and sulphonamides) (Dewulf et al., 2007). The 
dfrA1, dfrA12, dfrA15 and dfrA17 genes are documented to be carried on mobile genetic 
elements (i.e. integron classes), harboring resistance genes to at least three antimicrobials, 
and thus conferring multiple resistance (Ahmed et al., 2009). Other antibiotic resistances (i.e. 
ampicillin resistance) although found, were not strongly related to the presence of mobile 
genetic elements (Hoyle et al., 2005). Our PCR results in this study revealed similar 
observations within our collection of E.coli strains to other studies, although the conjugation 
results show that even isolates with single resistance (to ampicillin) transferred resistance 
(although not MDR). Thus, mobile genetic elements could also be responsible for single 
resistance and antimicrobial therapy might have resulted in such selection. The type of 
resistance and the identified genes (i.e. ampicillin resistance) could also be related to the 
type of antimicrobial therapy administered (e.g. cephalosporins). Such revelations, if proven 
by further studies, would mean that this kind of element may acquire further resistance 
genes in the future and help the dissemination and development of antibiotic resistance. 
The importance of mobile gene pools in the spread of antibiotic resistance has been 
highlighted through comprehensive genomic analysis (Fricke et al., 2008). In our survey, a 
high proportion of the isolates tested in conjugation experiments were able to transfer 
resistance. Dfr17 was the most prevalent trimethoprim resistance gene identified among the 
positive PCR isolates and dfr1 was the second most prevalent. tetA was the most prevalent 
tetracycline resistant gene. This might indicate that the dfr17 and tetA resistant genes are 
more involved in the MDR mechanisms and most likely to be integrated within mobile 
genetic elements. The tem gene was also the most prevalent ampicillin resistant gene among 
the isolates and the catI gene was mostly found in MDR isolates. The dfr17 is extensively 
reported to be involved in mobile genetic elements (Van et al., 2007). This, along with the 
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conjugation results, suggests that these elements are present in the hospital environment or 
that they are already constituents of the horses’ intestinal flora. The referral hospital deals 
with horses in the area and horses are likely to be referred more than once to this hospital, 
which might lead to increases in the dissemination of resistance phenotypes in horses. The 
similarity between MDR phenotypes among collected strains can be epidemiologically 
important and molecular characterization (i.e. PFGE) in future studies will enhance our 
understanding of the phenomena. 
The florfenicol resistant isolates were positive by PCR (five out of seven were positive for 
catI) and the mechanisms of this resistance require further investigation. However 
florfenicol resistance has been documented in E. coli of animal origin (Singer et al., 2004) and 
it has been shown that floR genetic determinants and others (i.e. cmlA, cat1, cat2) were also 
largely related to florfenicol resistance (Li et al., 2007). Others have shown that floR 
mediated resistance to chloramphenicol and florfenicol is plasmid mediated and also carries 
resistance to other genes (Blickwede et al., 2007; Kehrenberg et al., 2008). Recent molecular 
analyses have suggested that florfenicol resistance is strongly due to horizontal rather than 
clonal dissemination (Kehrenberg et al., 2008). This correlates with our results, in that 
florfenicol resistance is entirely documented among MDR isolates (although not proven 
transconjugants by our experiments). The horses in this study had never been treated with 
these classes of drugs, implicating a mobile genetic system in the acquisition of resistance 
from other animals or the environment.  
5. Conclusions  
No association between therapy and resistance profile was found in this study. However, 
the prevalence of antimicrobial resistance, and of MDR strains, did increase during 
hospitalization and subsequently decreased upon release from hospital. Thus therapy and 
the general environment of the hospital do appear to select for resistance and resistant 
isolates may disseminate once horses have been discharged, leading to clinical and public 
health concerns. 
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